NCT00078767View on ClinicalTrials.gov

Pharmacologic Treatment of PTSD in Sexually Abused Children

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Stress Disorders, Post-Traumatic
Interventions
BEHAVIORAL

Trauma-Focused Cognitive Behavioral Therapy

12 weeks of Trauma-Focused CBT (TF-CBT)for youth and parent

DRUG

Sertraline Pill

12 weeks of Sertraline pill, flexible dosage of 50-150 mg/day, to be administered while receiving TF-CBT

DRUG

Placebo Oral Tablet

12 weeks of Placebo pill, flexible dosage, of 50-150 mg/day, to be administered while receiving TF-CBT

Trial Locations (1)

15212

Allegheny General Hospital Center for Traumatic Stress in Children and Adolescents, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

OTHER

NCT00078767 - Pharmacologic Treatment of PTSD in Sexually Abused Children | Biotech Hunter | Biotech Hunter